NISO Biomed srl
Activity description
ENDOFASTER analyses gastric juice and provides real time information to the endoscopist, thus potentiating and integrating the gastroscopic investigation with a comparison of visual observation and chemical tests. The combination of this information and visual inspection improves diagnostic capacity and bioptic sampling strategy.
It is a device that increase the potentiality of the endoscope during the diagnosis in real time of Helicobacter Pylori and the conditions of ipo-chloridria, that they are considering the principal factors of neoplastic risk of cancer of stomach.
ENDOFASTER provides:
1. diagnosis of Helicobacter pylori through urease test on gastric juice;
2. test of gastric pH and detection of hypochlorhydric conditions and correlation with neoplastic risk conditions;
3. control of effectiveness of PPI therapies for gastroesophageal reflux disease;
4. cost Saving originated from Histology reduction and HP test on biopsy approved from HTA (Health Technology Assessment).
